レプチンは,人間の肥満に関連する高血圧を媒介するものではありません
Rebecca J Brown1, Cristina Adelia Meehan1, Phillip Gorden1
1Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Cell
|August 2, 2015
まとめ
高血圧と肥満は関係がありますが,ヒトではホルモン レプチンが原因ではないかもしれません. 人 の 中 で 高血圧 を 引き起こす 原因 は 特定 さ れ て い ない 別 の 原因 で ある か も しれ ませ ん.
科学分野:
- 生理学
- 内分泌学
- 心血管科学
背景:
- 肥満と高血圧は共病である.
- 食欲と代謝を調節するホルモンであるレプチンは,ネズミのモデルにおける高血圧と肥満の関連を媒介することに関与している.
- 人間におけるこの関連性の正確なメカニズムは不明である.
研究 の 目的:
- ヒトにおける高血圧と肥満の関係におけるレプチンの役割を調査する.
- 肥満患者の高血圧に寄与する潜在的な代替因子を調査する.
主な方法:
- この研究は,既存の文献をレビューし,提案されたメカニズムについて議論します.
- 肥満と高血圧に対するネズミと人間の生理学的反応の比較分析
主要な成果:
- ネズミの高血圧を媒介する レプチンの役割が示唆されている.
- データによると,このレプチン媒介経路はヒトでは保存されない可能性がある.
- 人口における高血圧の原因は,まだ特定されていない重要な要因である可能性が高い.
結論:
- 人間における肥満と高血圧の間の確立された関連は,マウスで観察されたものとは異なるメカニズムを含んでいる可能性があります.
- 肥満患者の高血圧の原因となる特定の要因を特定するには,さらなる研究が必要である.
関連する概念動画
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
287
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
287
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
394
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
394
Drug Dosing: Obese Patients
343
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
343
Regulation of Food Intake
3.2K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.2K
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Overview of Lipid Metabolism
6.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.8K


